[Amyloidosis-a dreaded complication of juvenile chronic arthritis (JCA). (author's transl)].
Our studies describe symptoms, clinical course and prognosis of 60 children (out of a total of 2063 patients) suffering from chronic arthritis complicated with amyloidosis. Amyloidosis is predominantly caused by the systemic subgroup of juvenile chronic arthritis, which is characterized by high inflammation activity. The amyloidosis and the sequelae are one of the main causes of death in JCA (27 of the 90 lethal cases in our juvenile chronic arthritis unit were connected with amyloidosis). Proteinuria is the most frequent sign in the early stage of the amyloidosis. Early diagnose and treatment by cytostatic drugs like chlorambucil seems to improve the prognosis. The cumulative survival results in the existence of two different subgroup of amyloidosis.
D000293:Adolescent; D000686:Amyloidosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D001171:Arthritis, Juvenile / Q000150:complications*; D002648:Child; D002675:Child, Preschool; D002699:Chlorambucil / Q000627:therapeutic use; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D011379:Prognosis; D011507:Proteinuria / Q000209:etiology
D002699:Chlorambucil
Die Amyloidose-eine gefürchtete Folgekrankheit der juvenilen chronischen Arthritis (JCA).